Wang, D., Zhou, J., Fang, W., Huang, C., Chen, Z., Fan, M., . . . Luo, L. (2022). A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer. KeAi Communications Co., Ltd.
芝加哥风格引文Wang, Duo, et al. A Multifunctional Nanotheranostic Agent Potentiates Erlotinib to EGFR Wild-type Non-small Cell Lung Cancer. KeAi Communications Co., Ltd, 2022.
MLA引文Wang, Duo, et al. A Multifunctional Nanotheranostic Agent Potentiates Erlotinib to EGFR Wild-type Non-small Cell Lung Cancer. KeAi Communications Co., Ltd, 2022.
警告：这些引文格式不一定是100％准确.